ACRS Q4 2022 Earnings — Aclaris Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ACRSAclaris Therapeutics, Inc.

$435M

Q4 2022 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$8M+416.5% YoY

Gross Profit

$6M80.5% margin

Operating Income

-$29M-375.1% margin

Net Income

-$28M-356.4% margin

EPS (Diluted)

$-0.50

QoQ Revenue Growth

-59.2%

Cash Flow

Operating Cash Flow

-$19M

Free Cash Flow

-$19M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$255M

Total Liabilities

$57M

Stockholders' Equity

$198M

Cash & Equivalents

$45M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$8M	$2M	+416.5%
Gross Profit	$6M	$352,000	+1672.4%
Operating Income	-$29M	-$23M	-27.0%
Net Income	-$28M	-$23M	-21.2%

Revenue Segments

License and Service

$7M87%

Contract research

$866,00011%

Other

$165,0002%